Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index; 20 of the 27 sources its claims cite were checked for support.

Pharmacological or non-pharmacological interventions for treatment of common mental disorders associated with Tuberculosis: A systematic review

Open access
Farooq, Saeed, Tunmore, Jessica, Comber, Rifat · 2021 · Chronic Respiratory Disease

Abstract

We aimed to review the literature on interventions for treating Common Mental Disorders (CMD) in people with Tuberculosis (TB). We followed PRISMA guidelines and the protocol was registered at PROSPERO. The electronic databases (PsycInfo, CINAHL, Medline, Google Scholar, Embase) were searched from 1982 to 2020. 349 relevant records were screened, with 26 examined at full text. 13 studies were included totalling 4326 participants. A meta-analysis was not possible due to nature of data, thus descriptive synthesis was conducted. Eleven studies evaluated psychosocial interventions, which significantly improved adherence or cure rates from TB, anxiety and depression. The elements of effective psychosocial interventions included; combating stigma, socioeconomic disadvantage, managing associated guilt and fear of contagion, and explanatory models of illness in local population. Two articles evaluated pharmacological interventions (antidepressants and Vitamin D). This is the first systematic review of interventions to treat CMD in TB. The studies were mostly low quality and mental health outcomes were not adequately described. However, this review suggests that it is feasible to develop and test interventions for improving mental health outcomes and enhancing treatment adherence in TB. © The Author(s) 2021.

Overview

CoChat Summary

TL;DR

This systematic review identified 13 studies (4,326 participants) on pharmacological and psychosocial interventions for common mental disorders in people with TB, and found mostly positive signals for psychosocial approaches. A meta-analysis was not possible, and the evidence was limited by low study quality and poorly reported mental health outcomes.

Key findings

  • The review included 13 studies with 4,326 participants; 11 evaluated psychosocial interventions and 2 evaluated pharmacological interventions.
  • Psychosocial interventions were reported to improve TB adherence or cure rates, and in some studies also anxiety and depression; the abstract states effective elements included combating stigma, socioeconomic disadvantage, managing guilt and fear of contagion, and local explanatory models of illness.
  • Reported outcomes included:
  • Pharmacy-based intervention: depression improved from moderate depression 54.26% to 11.43%, and severe depression 37.14% to zero at the end of intervention.
  • Psychotherapy vs treatment as usual: TB treatment adherence improved 83% vs 47%, and cure rates 72% vs 42%.
  • Psychological intervention (counselling + education): treatment non-adherence was 9.5% vs 25.4% in control; psychological distress improved with Kessler-10 scores 14 vs 19 at follow-up.
  • Pharmacological studies: imipramine improved depression in 86.7% vs 48.3% control (P < 0.01), while vitamin D lowered Beck Depression Inventory scores in both groups but showed no significant between-group difference after 8 weeks (P = 0.38).
  • The review notes that all studies reported improvement in adherence or cure rates from TB/MDR-TB, but specific anxiety/depression outcomes were often not adequately described.

Methods

  • Systematic review conducted according to PRISMA, with a protocol registered in PROSPERO.
  • Searched PsycInfo, CINAHL, Medline, Embase, PubMed, and Google Scholar for studies from 1982 to 2020; included studies of people older than 5 years with TB or MDR-TB and interventions for CMD.
  • Two reviewers independently screened and extracted data; due to heterogeneity and inconsistent reporting, the authors conducted a descriptive/narrative synthesis rather than a meta-analysis.

Limitations

  • The paper states that included studies were mostly low quality, with poorly reported mental health outcomes; almost all controlled trials had high or unclear risk of bias.
  • The review was limited to English-language studies, so relevant studies in other languages may have been missed; the authors also note possible publication bias.
  • Evident from the text: the evidence base was small and heterogeneous, with only 13 studies, diverse designs and interventions, and in some studies no specific mental health outcomes were reported, which prevented pooling.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1177/14799731211003937

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. PRISMA diagram.
Figure 1. PRISMA diagram.CC BY · PubMed Central
Figure 2. Risk of bias assessment.
Figure 2. Risk of bias assessment.CC BY · PubMed Central

Verification

Claims the paper makes

13 Valid · 1 Not valid · 3 Not checked · 23 Own results and interpretations

8 more claims

Create a free account to see all 40 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 15
  • It may state two separate claims as one. 19

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 30 references

Research works printed but not linked: 7

  1. National Collaborating Centre for Mental Health (UK). Common Mental Health Disorders: Identification and Pathways to Care. Leicester (UK): British Psychological Society. (NICE Clinical Guidelines, No. 123.) 2, COMMON MENTAL HEALTH DISORDERS, https://www.ncbi.nlm.nih.gov/books/NBK92254/ (2011, accessed 31 October 2020).
  2. Pachi A, 2013, Tuberc Res Treat, 2013, 489865
  3. Syakiratin Q, 2019, Berita Kedokteran Masyarakat, 35, 155
  4. Kaukab I, 2015, Lat Am J Pharm, 34, 1403
  5. Meghnani ML, 1988, Lung India, 6, 22
  6. Van Ginneken N, 2013, Cochrane Database Syst Rev, CD009149
  7. Van Ginneken N, 2011, Cochrane Database Syst Rev, CD009149

Cited by

See all 31

Metadata

Authors
Farooq, S., Tunmore, J., & Comber, R.
Affiliations
Midlands Partnership NHS Foundation Trust (GB)
Corresponding author
Farooq, Saeed
Venue
Chronic Respiratory Disease
Published
2021-01-01
Volume
18
Pages
14799731211003937-14799731211003937
ISSN
  • 1479-9723 (ISSN-L)
  • 1479-9731
OpenAlex
W3159773707
Cited by
31
References
30
Citations by year
2026: 3 · 2025: 6 · 2024: 11 · 2023: 8 · 2022: 1 · 2021: 1
FWCI
0.61
Type
journal article
Language
en
Open access
Locations
  • Chronic Respiratory Disease (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Keele Research Repository (Keele University) (submittedVersion, cc-by)
Funders
National Institute for Health and Care Research (NIHR201773)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
Keywords
common mental disorders, tuberculosis, psychosocial interventions, pharmacological interventions, antidepressants, vitamin D, medication adherence, stigma, depression, anxiety, guilt, fear of contagion, explanatory models of illness, socioeconomic deprivation
MeSH terms
Anxiety, Mental Disorders, Humans, Tuberculosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacological or non-pharmacological interventions for treatment of common mental disorders associated with Tuberculosis: A systematic review. https://app.cochat.ai/papers/10.1177/14799731211003937
The paper
Farooq, S., Tunmore, J., & Comber, R. (2021). Pharmacological or non-pharmacological interventions for treatment of common mental disorders associated with Tuberculosis: A systematic review. Chronic Respiratory Disease. https://doi.org/10.1177/14799731211003937

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.